Pyxis Oncology, Inc.
PYXS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001782223
No open-market purchases or sales by Pyxis Oncology, Inc. insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $101.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Pyxis Oncology, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +16 vs. Q4 2022
- Shares held
- 10.4M
- −9.41M (−47.6%) vs. Q4 2022
- Total value
- $41.5M
- +$15.0M (+56.8%) vs. Q4 2022
- New holders
- 24
- 8 more added
- Sold out
- 8
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PYXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 76 | $101.1M |
| Q1 2026 | 78 | $40.5M |
| Q4 2025 | 79 | $34.7M |
| Q3 2025 | 73 | $59.7M |
| Q2 2025 | 74 | $30.2M |
| Q1 2025 | 89 | $29.6M |
| Q4 2024 | 99 | $49.2M |
| Q3 2024 | 92 | $102.3M |
| Q2 2024 | 80 | $93.1M |
| Q1 2024 | 71 | $97.7M |
| Q4 2023 | 51 | $15.8M |
| Q3 2023 | 54 | $15.4M |
| Q2 2023 | 48 | $24.6M |
| Q1 2023 | 47 | $41.5M |
| Q4 2022 | 31 | $26.5M |
| Q3 2022 | 38 | $38.3M |
| Q2 2022 | 39 | $47.7M |
| Q1 2022 | 45 | $76.1M |
| Q4 2021 | 51 | $199.9M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Pyxis Oncology, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| West Branch Capital LLC | 25 | $101 | 0.00% | +25 | New |
| The PNC Financial Services Group, Inc. | 100 | $401 | 0.00% | +100 | New |
| Coston, McIsaac & Partners | 383 | $1.00K | 0.00% | +383 | New |
| GWM Advisors LLC | 250 | $1.00K | 0.00% | +250 | New |
| Cubist Systematic Strategies, LLC | 1,569 | $6.29K | 0.00% | +1,569 | New |
| Wells Fargo & Company | 2,163 | $8.67K | 0.00% | +2,003+1,251.9% | Added |
| Point72 Middle East FZE | 2,447 | $9.81K | 0.00% | +2,447 | New |
| UBS Group AG | 2,955 | $11.8K | 0.00% | +2,955 | New |
| JPMorgan Chase & Co | 5,033 | $20.0K | 0.00% | +5,033 | New |
| Bank of Montreal | 10,000 | $29.6K | 0.00% | +10,000 | New |
| Advisor Group Holdings, Inc. | 8,000 | $32.1K | 0.00% | +8,000 | New |
| Tower Research Capital LLC (TRC) | 10,866 | $43.0K | 0.00% | +4,688+75.9% | Added |
| Dimensional Fund Advisors LP | 12,087 | $48.5K | 0.00% | +12,087 | New |
| LPL Financial LLC | 13,664 | $54.8K | 0.00% | +13,664 | New |
| Tudor Investment Corp Et Al | 13,624 | $55.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 13,768 | $55.2K | 0.00% | +13,768 | New |
| Charles Schwab Investment Management Inc | 17,739 | $71.1K | 0.00% | 00.0% | Unchanged |
| Sawtooth Solutions, LLC | 18,110 | $72.6K | 0.00% | +18,110 | New |
| Bleakley Financial Group, LLC | 18,110 | $72.6K | 0.00% | +18,110 | New |
| Kingsview Wealth Management, LLC | 20,000 | $80.2K | 0.00% | +20,000 | New |
| Bank of America Corp | 23,492 | $94.2K | 0.00% | −40,103−63.1% | Reduced |
| Deutsche Bank AG | 25,000 | $100.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 27,129 | $108.8K | 0.00% | −1,535,669−98.3% | Reduced |
| Northern Trust Corp | 31,507 | $126.3K | 0.00% | +5,109+19.4% | Added |
| Acadian Asset Management LLC | 32,506 | $130.0K | 0.00% | −39,196−54.7% | Reduced |
| Goldman Sachs Group Inc | 35,424 | $142.1K | 0.00% | +35,424 | New |
| Squarepoint Ops LLC | 37,945 | $152.2K | 0.00% | +37,945 | New |
| University of Chicago | 48,731 | $195.4K | 0.09% | 00.0% | Unchanged |
| State Street Corp | 62,289 | $249.8K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 69,782 | $279.0K | 0.00% | +69,782 | New |
| ExodusPoint Capital Management, LP | 70,000 | $281.0K | 0.00% | +70,000 | New |
| Royal Bank of Canada | 72,545 | $291.0K | 0.00% | +72,545 | New |
| Jane Street Group, LLC | 75,430 | $302.5K | 0.00% | +75,430 | New |
| Harvest Investment Services, LLC | 91,047 | $365.1K | 0.28% | +91,047 | New |
| Renaissance Technologies LLC | 94,200 | $378.0K | 0.00% | +10,600+12.7% | Added |
| Barclays PLC | 118,223 | $474.1K | 0.00% | −829,828−87.5% | Reduced |
| Morgan Stanley | 168,576 | $676.0K | 0.00% | +62,157+58.4% | Added |
| Bridgeway Capital Management, LLC | 170,295 | $682.9K | 0.02% | 00.0% | Unchanged |
| BlackRock Inc. | 212,288 | $851.3K | 0.00% | +956+0.5% | Added |
| Geode Capital Management, LLC | 239,351 | $959.8K | 0.00% | +35,417+17.4% | Added |
| Point72 Asset Management, L.P. | 251,800 | $1.01M | 0.00% | +251,800 | New |
| Cormorant Asset Management, LP | 272,537 | $1.09M | 0.07% | −396,317−59.3% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 530,692 | $2.13M | 0.04% | −233,714−30.6% | Reduced |
| Tekla Capital Management LLC | 708,303 | $2.84M | 0.11% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,062,549 | $4.26M | 0.00% | +144,722+15.8% | Added |
| Tang Capital Management LLC | 2,481,662 | $9.95M | 1.48% | −989,038−28.5% | Reduced |
| Laurion Capital Management LP | 3,170,803 | $12.7M | 0.57% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −2,938,851−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −848,252−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −669,158−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −357,537−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −58,862−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −35,477−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −31,334−100.0% | Sold out |